Management Team

CRH Management Team

CRH Medical Corporation is led by an experienced, passionate team of executives:


Edward Wright

Edward Wright - Chief Executive Officer, Director

Mr. Wright became CEO and director of the company in September of 2006. Prior to joining CRH he gained extensive management experience in global luxury brands at Richemont, the holding company for some of the world’s leading luxury goods. As President of Baume & Mercier first, and then as Executive Vice-President of North America Retail for Cartier, Mr. Wright developed an ability for building solid relationships with customers and business partners alike.

Upon arriving at CRH, Mr. Wright was tasked with maximizing the value of CRH’s O’Regan System. He quickly determined that CRH needed to transition from a retail model to a wholesale model and by introducing it to the gastrointestinal (“GI”) community in the US, he created a paradigm shift for gastrointestinal doctors (“GIs”) by extending their continuum of care for patients.

To maximize the value of CRH, Mr. Wright leveraged our relationships with the GI community leading to the launch of CRH Anesthesia Management, a business focused on providing GI anesthesia services to Ambulatory Surgical Centers (“ASCs”) across the US. CRH Anesthesia is now the primary driver of the company’s revenue and is positioned as one of the leading GI anesthesia brands in the US with outstanding growth potential.

Under Mr. Wright’s management CRH has become a profitable company with strong cash flow generation and access to North American capital markets to fund the company’s long-term growth strategy.

Mr. Wright is a member of the Young Presidents’ Organization and Chair of Vancouver College’s Board of Directors.
Richard Bear

Richard Bear - Chief Financial Officer

Mr. Bear has been an officer of the company since March of 2006. Prior to CRH, he worked at ID Biomedical Corporation, first as Vice President of Finance and then as Chief Financial Officer.

Since joining CRH, Mr. Bear has planned and executed all of our financial transactions including capital private placement, debt issuance and restructuring, establishment and extension of our existing credit facility with US and Canadian financial institutions, and listing of our shares on the NYSE Market.

Since December of 2014, Mr. Bear has also been in charge of the negotiation and financing, as well as the accounting and financial integration of CRH Anesthesia Management’s acquisitions into our organization.

Mr. Bear has a degree in Business Administration from the University of Washington and has received a Certified Public Accountant (CPA) designation.
Mitchel Guttenplan, MD, FACS

Mitchel Guttenplan, MD, FACS - Medical Director

Dr. Guttenplan joined CRH in 2006 as the Co-Medical Director of the Centers for Colorectal Health in Metropolitan Atlanta. He became Medical Director for CRH in 2008, when the company migrated the O’Regan System to a wholesale, direct-to-physician business model. As our Medical Director, Dr. Guttenplan was responsible for designing and implementing the O’Regan training program and he has trained many hundreds of surgeons and gastroenterologists in the use of CRH’s O'Regan System.

Dr. Guttenplan is considered one of the foremost experts in hemorrhoid banding in the US and has been a guest lecturer at numerous medical schools, hospitals and GI societies, as well as regional and national scientific meetings. He graduated from the Emory University School of Medicine and completed his residency in General Surgery at the Emory University Affiliated Hospitals. Dr. Guttenplan has been a practicing Board Certified general surgeon since 1987.
Jay Kreger

Jay Kreger - President, CRH Anesthesia

Mr. Kreger has over 25 years of diversified experience, focusing on Business Development and Operations. Prior to joining CRH, he held the role of Vice President of Development for the Ambulatory Surgery Division at Hospital Corporation of America (HCA). Mr. Kreger received a BA in Finance at Michigan State University and a MBA at Wayne State University.
Back to topˆ
We're a stable, profitable company respected by both patients and physicians. Learn more »